You are here:
NICE
NICE Guidance
Conditions and diseases
Cancer
Head and neck cancers
Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck
Technology appraisal guidance
Reference number:
TA145
Published:
25 June 2008
Guidance
Tools and resources
Information for the public
Evidence
History
Merck Serono
Appeals received
Initial scrutiny letter
This page was last updated:
30 March 2010